TerminatedPhase 2NCT03927222

Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma

Studying Glioblastoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Mustafa Khasraw, MBChB, MD, FRCP, FRACP
Principal Investigator
Mustafa Khasraw, MBChB, MD, FRCP, FRACP
Duke University
Intervention
Human CMV pp65-LAMP mRNA-pulsed autologous DCs containing GM CSF(biological)
Enrollment
6 enrolled
Eligibility
18 years · All sexes
Timeline
2019 – 2023

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03927222 on ClinicalTrials.gov

Other trials for Glioblastoma

Additional recruiting or active studies for the same condition.

See all trials for Glioblastoma →

← Back to all trials